Eli Lilly and Company vs Johnson & Johnson
Eli Lilly and Company is worth $1.061T, 1.6× the $650.673B market cap of Johnson & Johnson. Updated daily.
| Metric | ||
|---|---|---|
| Market cap | $1.061T | $650.673B |
| Global rank | #1 | #2 |
| Share price | $1,189.41 | $270.00 |
| Change | -2.11% | +3.93% |
| Revenue | $65.179B | $94.193B |
| Net income | $20.640B | $26.804B |
| Country | United States | United States |
| Sector | Healthcare | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Eli Lilly and Company bigger than Johnson & Johnson?
- Eli Lilly and Company has a market cap of $1.061T against $650.673B for Johnson & Johnson, making it 1.6 times as valuable.
- Which company earns more, LLY or JNJ?
- Eli Lilly and Company reported net income of $20.640B and Johnson & Johnson reported $26.804B in their most recent annual periods.